Related Experiment Video
Updated: Jul 8, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Endovascular treatment of aortic coarctation: long-term effects on hypertension
Carmine Musto1, Alberta Cifarelli, Edoardo Pucci
1Interventional Cardiology Unit, S. Camillo/Forlanini Hospital, Circonvallazione Gianicolense, 87, 00151 Rome, Italy.
Insights
Endovascular treatment for aortic coarctation (CoA) is safe in adolescents and adults, but 33% experienced persistent hypertension. Long-term monitoring, including exercise tests, is crucial for managing blood pressure after CoA repair.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Pediatric Cardiology
Background:
- Aortic coarctation (CoA) management via endovascular techniques is established as safe.
- Limited data exist on the long-term efficacy of endovascular CoA treatment in resolving hypertension.
- Adolescent and adult patients with CoA require evaluation for long-term outcomes after endovascular intervention.
Purpose of the Study:
- To assess the immediate and long-term clinical and hemodynamic outcomes of endovascular treatment for aortic coarctation (CoA) in adolescent and adult patients.
- To evaluate the effectiveness of endovascular CoA repair in managing hypertension.
- To determine the safety and durability of transcatheter interventions for CoA.
Main Methods:
- A consecutive series of 21 adolescent and adult patients with CoA underwent successful transcatheter intervention.
- Follow-up included cardiological examinations, blood pressure (BP) assessment, echocardiography, 24-hour ambulatory BP monitoring (ABP), exercise testing, and spiral computed tomography.
- Hemodynamic parameters, including CoA diameter, stenosis degree, and Doppler gradient, were measured pre- and post-intervention.
Main Results:
- Successful endovascular repair significantly reduced CoA diameter and stenosis, with Doppler gradients decreasing from 58.8+/-16.9 to 10.5+/-4.9 mmHg (p<0.001).
- Left ventricular mass also decreased post-intervention (p<0.001).
- Despite treatment, 33% of patients (7/21) exhibited persistent hypertension at follow-up, with 14% hypertensive on ABP monitoring and 22% showing pathological BP response during exercise tests. The mean number of antihypertensive medications decreased from 1.5 to 0.5 (p<0.05).
Conclusions:
- Endovascular treatment for native or recurrent aortic coarctation in adolescents and adults is a safe procedure.
- A significant proportion (33%) of patients experience persistent hypertension post-intervention, underscoring the need for lifelong monitoring.
- Meticulous clinical follow-up, including exercise testing, is essential to monitor blood pressure response and assess effort tolerance in patients treated for CoA.
Introduction:
Endovascular management of aortic coarctation (CoA) is safe but few data are available concerning the long-term cure of hypertension. Aim of this study was to evaluate immediate and long-term clinical and haemodynamic outcome in a consecutive series of adolescent and adult patients with CoA submitted to endovascular treatment.
Methods:
A total of 21 adolescent and adult patients underwent successful transcatheter intervention of CoA. Follow-up comprised cardiological examination with special attention to blood pressure (BP), echocardiogram, 24/h ambulatory blood pressure monitoring (ABP), exercise test and spiral computed tomography.
Results:
Pre-intervention CoA diameter and degree of stenosis were 4.8+/-2.1 mm and 73.7+/-9.8%, respectively, and 14.8+/-3.0 mm and 13.5+/-6.5% post-intervention (p<0.001). Systolic arterial hypertension persisted in 2 patients at rest (9.5%). Mean number of antihypertensive medications per patient was 1.5+/-1.1 and 0.5+/-0.9 at 1 year after treatment (p<0.05). At ABP 3 patients (14%) were hypertensive. The Doppler gradient across the coarctation site decreased from 58.8+/-16.9 to 10.5+/-4.9 mmHg (p<0.001) as well as left ventricular mass (199+/-14.6 and 189.3+/-9.1; p<0.001). Overall, 18 patients (86%) underwent a treadmill exercise test and 4 patients (22%), normotensive at rest, showed a pathological blood pressure response. Overall, 7/21 patients (33%) showed persistent hypertension.
Conclusion:
Endovascular treatment of native or recurrent CoA in adolescent and adult patients is safe but 33% of patients showed persistent hypertension. Meticulous clinical follow-up is mandatory, including an exercise test in order to monitor eventual blood pressure increase and to assess effort tolerance.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Aneurysm II: Clinical Manifestations and Diagnostic Studies